European Pharmaceutical Review

JANUARY 5, 2024

Endocrine therapy in combination with CDK4/6 inhibitors is the current standard treatment for ER+/HER2- breast cancer patients with advanced or metastatic disease.

Medicine 107

Medicine Biopharma Patients Pharmaceutical 107

European Pharmaceutical Review

JANUARY 8, 2024

The European Commission (EC) has now granted a marketing authorisation for biopharma company UCB’s treatment, as an add-on to standard therapy in patients who have this rare autoimmune condition. It is indicated as a subcutaneous, add-on to standard therapy in these patients.

Biopharma 96

Biopharma Medicine Healthcare Healthcare 96

PharmaTech

JANUARY 4, 2024

Recognizing the urgency associated with short shelf-life products, Eurofins BioPharma Product Testing has developed a comprehensive set of services to address the need for swift and reliable testing. Eurofins acknowledges the significance of Cell and Gene Therapies, particularly Autologous Cell Therapies , in the healthcare industry.

Biopharma 40

Biopharma Safety Healthcare Healthcare 40

Clarivate

JANUARY 8, 2024

These new treatments hold tremendous promise to advance patient care and fuel the next generation of medical breakthroughs. New therapeutics that may significantly reduce the burden existing treatments place on patients and clinicians. Clarivate Cortellis data indicate a 75% probability of success for diabetic retinopathy in the U.S.

Marketing 59

Marketing Patients Healthcare Healthcare 59

Veeva

JANUARY 30, 2024

But what do these really mean, and how can biopharma companies tailor experiences for HCPs and achieve their business objectives? Biopharmas need to have in place a personalized HCP strategy (Figure 1.1) We recently held a webinar for our customers and explored solutions, which we will cover in this article.

Biopharma 52

Biopharma Safety Sales CRM 52